Aileen McHarg
About
In The Last Decade
Aileen McHarg
16 papers receiving 349 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 159
- Pathology and Forensic Medicine 137
- Physiology 134
- Psychiatry and Mental health 127
- Cardiology and Cardiovascular Medicine 85
Countries citing papers authored by Aileen McHarg
This map shows the geographic impact of Aileen McHarg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aileen McHarg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aileen McHarg more than expected).
Fields of papers citing papers by Aileen McHarg
This network shows the impact of papers produced by Aileen McHarg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aileen McHarg. The network helps show where Aileen McHarg may publish in the future.
Co-authorship network of co-authors of Aileen McHarg
This figure shows the co-authorship network connecting the top 25 collaborators of Aileen McHarg. A scholar is included among the top collaborators of Aileen McHarg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aileen McHarg. Aileen McHarg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 23 | |
| 3 | 27 | |
| 4 | 30 | |
| 5 | 1 | |
| 6 | PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2 | 7 |
| 7 | 12 | |
| 8 | 1 | |
| 9 | 38 | |
| 10 | 7 | |
| 11 | 21 | |
| 12 | 63 | |
| 13 | 26 | |
| 14 | 12 | |
| 15 | 79 | |
| 16 | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.